805 related articles for article (PubMed ID: 15528476)
1. Sulfatides activate platelets through P-selectin and enhance platelet and platelet-leukocyte aggregation.
Merten M; Beythien C; Gutensohn K; Kühnl P; Meinertz T; Thiagarajan P
Arterioscler Thromb Vasc Biol; 2005 Jan; 25(1):258-63. PubMed ID: 15528476
[TBL] [Abstract][Full Text] [Related]
2. Platelet P-selectin plays an important role in arterial thrombogenesis by forming large stable platelet-leukocyte aggregates.
Yokoyama S; Ikeda H; Haramaki N; Yasukawa H; Murohara T; Imaizumi T
J Am Coll Cardiol; 2005 Apr; 45(8):1280-6. PubMed ID: 15837262
[TBL] [Abstract][Full Text] [Related]
3. The complement factor properdin induces formation of platelet-leukocyte aggregates via leukocyte activation.
Ruef J; Kuehnl P; Meinertz T; Merten M
Platelets; 2008 Aug; 19(5):359-64. PubMed ID: 18791942
[TBL] [Abstract][Full Text] [Related]
4. Role for sulfatides in platelet aggregation.
Merten M; Thiagarajan P
Circulation; 2001 Dec; 104(24):2955-60. PubMed ID: 11739312
[TBL] [Abstract][Full Text] [Related]
5. Lidocaine priming reduces ADP-induced P-selectin expression and platelet-leukocyte aggregation.
Huang GS; Lin TC; Wang JY; Ku CH; Ho ST; Li CY
Acta Anaesthesiol Taiwan; 2009 Jun; 47(2):56-61. PubMed ID: 19527965
[TBL] [Abstract][Full Text] [Related]
6. Can hypertonic saline influence platelet P selectin expression and platelet-leukocyte aggregation?
Huang GS; Hu MH; Lee CH; Tsai CS; Lin TC; Li CY
Am J Emerg Med; 2010 Jan; 28(1):37-43. PubMed ID: 20006199
[TBL] [Abstract][Full Text] [Related]
7. Do platelet apoptosis, activation, aggregation, lipid peroxidation and platelet-leukocyte aggregate formation occur simultaneously in hyperlipidemia?
Sener A; Ozsavci D; Oba R; Demirel GY; Uras F; Yardimci KT
Clin Biochem; 2005 Dec; 38(12):1081-7. PubMed ID: 16253220
[TBL] [Abstract][Full Text] [Related]
8. The periodontal anaerobe Porphyromonas gingivalis induced platelet activation and increased aggregation in whole blood by rat model.
Yu KM; Inoue Y; Umeda M; Terasaki H; Chen ZY; Iwai T
Thromb Res; 2011 May; 127(5):418-25. PubMed ID: 21334044
[TBL] [Abstract][Full Text] [Related]
9. Platelet activation as a marker for in vivo prothrombotic activity: detection by flow cytometry.
Tomer A
J Biol Regul Homeost Agents; 2004; 18(2):172-7. PubMed ID: 15471223
[TBL] [Abstract][Full Text] [Related]
10. Effect of prostacyclin on platelets, polymorphonuclear cells, and heterotypic cell aggregation during hemofiltration.
Kozek-Langenecker SA; Spiss CK; Michalek-Sauberer A; Felfernig M; Zimpfer M
Crit Care Med; 2003 Mar; 31(3):864-8. PubMed ID: 12626998
[TBL] [Abstract][Full Text] [Related]
11. Detection of activated platelets in canine blood by use of flow cytometry.
Wills TB; Wardrop KJ; Meyers KM
Am J Vet Res; 2006 Jan; 67(1):56-63. PubMed ID: 16426212
[TBL] [Abstract][Full Text] [Related]
12. P-selectin, tissue factor and CD40 ligand expression on platelet-leucocyte conjugates in the presence of a GPIIb/IIIa antagonist.
Zhao L; Bath PM; May J; Lösche W; Heptinstall S
Platelets; 2003; 14(7-8):473-80. PubMed ID: 14713516
[TBL] [Abstract][Full Text] [Related]
13. Platelet aggregation-induced by caco-2 cells: regulation by matrix metalloproteinase-2 and adenosine diphosphate.
Medina C; Jurasz P; Santos-Martinez MJ; Jeong SS; Mitsky T; Chen R; Radomski MW
J Pharmacol Exp Ther; 2006 May; 317(2):739-45. PubMed ID: 16424148
[TBL] [Abstract][Full Text] [Related]
14. Platelet anaesthesia during extracorporeal circulation: differential effects of GP IIb/IIIa blockers on platelet activation marker P-selectin expression at hypothermia.
Straub A; Schiebold D; Wendel HP; Azevedo R; Dietz K; Ziemer G
Thromb Res; 2008; 122(3):383-9. PubMed ID: 18304613
[TBL] [Abstract][Full Text] [Related]
15. Moderate-intensity exercise suppresses platelet activation and polymorphonuclear leukocyte interaction with surface-adherent platelets under shear flow in men.
Wang JS; Liao CH
Thromb Haemost; 2004 Mar; 91(3):587-94. PubMed ID: 14983236
[TBL] [Abstract][Full Text] [Related]
16. Disabled-2 modulates homotypic and heterotypic platelet interactions by binding to sulfatides.
Welsh JD; Charonko JJ; Salmanzadeh A; Drahos KE; Shafiee H; Stremler MA; Davalos RV; Capelluto DG; Vlachos PP; Finkielstein CV
Br J Haematol; 2011 Jul; 154(1):122-33. PubMed ID: 21539534
[TBL] [Abstract][Full Text] [Related]
17. Relationships between optical aggregometry (type born) and flow cytometry in evaluating ADP-induced platelet activation.
Sbrana S; Della Pina F; Rizza A; Buffa M; De Filippis R; Gianetti J; Clerico A
Cytometry B Clin Cytom; 2008 Jan; 74(1):30-9. PubMed ID: 17630652
[TBL] [Abstract][Full Text] [Related]
18. Prevention of platelet glycoprotein IIb/IIIa activation by 3,4-methylenedioxy-beta-nitrostyrene, a novel tyrosine kinase inhibitor.
Wang WY; Wu YC; Wu CC
Mol Pharmacol; 2006 Oct; 70(4):1380-9. PubMed ID: 16837624
[TBL] [Abstract][Full Text] [Related]
19. C1q regulates collagen-dependent production of reactive oxygen species, aggregation and levels of soluble P-selectin in whole blood.
Skoglund C; Wetterö J; Bengtsson T
Immunol Lett; 2012 Feb; 142(1-2):28-33. PubMed ID: 22142906
[TBL] [Abstract][Full Text] [Related]
20. Chlamydia pneumoniae binds to platelets and triggers P-selectin expression and aggregation: a causal role in cardiovascular disease?
Kälvegren H; Majeed M; Bengtsson T
Arterioscler Thromb Vasc Biol; 2003 Sep; 23(9):1677-83. PubMed ID: 12842841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
